Counteracting vascular ageing with Traditional Chinese Medicine: Mechanisms at the cellular and molecular levels.
Xinyu Zhang, Tong Yin, Yanfei Cheng et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review synthesised research on how Traditional Chinese Medicine (TCM) interventions may affect vascular ageing, covering molecular mechanisms, relevant cell types and clinical studies. It describes proposed effects on telomeres, transcription, non-coding RNAs, mitochondria, oxidative stress, autophagy, immune and inflammatory balance, and communication among cells and tissues. The review also considers studies of different TCMs, including combinations with conventional chemical drugs. The abstract reports no pooled quantitative estimate or single headline clinical outcome; it presents a broad account of mechanisms and clinical evidence rather than a quantified treatment effect.
Key findings
- The review groups proposed mechanisms into genetic regulation, cellular function and homeostasis, and intercellular communication.
- Discussed mechanisms include effects on telomere integrity, mitochondrial function, oxidative stress, autophagy, and immune and inflammatory homeostasis.
- The review covers vascular smooth muscle and endothelial cells, endothelial progenitor cells, macrophages, monocytes, and adipocytes.
- Clinical studies reviewed include different TCM interventions and combinations with synthetic chemical drugs; no quantitative outcome is reported in the abstract.
Why it matters
Vascular ageing is linked to a growing cardiovascular disease burden, and this review maps the biological pathways and cell types through which TCM interventions have been studied. It may help clinicians and researchers understand the scope of the evidence and identify questions for further evaluation, while the abstract does not establish the size or certainty of clinical benefit.
What to keep in mind
The abstract provides no pooled effect estimate or specific clinical outcomes, and does not describe the included studies’ methods or quality, limiting assessment of the strength of clinical evidence.